Sponsor
Washington University Siteman Cancer Center
Clinical research sponsor
Clinical trials
3 shownAn Alternative Radiation Fractionation Strategy for Locally Advanced Non-Small Cell Lung Cancer (NSCLC)NCT01711697 · collaborator · 2012-09-04
UNKNOWNChemotherapy-Induced Cognitive ImpairmentNCT01578083 · collaborator · 2012-04-01
COMPLETED7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)NCT00031681 · collaborator · 2001-12-01
COMPLETEDSponsor roles
collaborator3
How to interpret this record
CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.